Short answer · Medically reviewed summary · Last updated: 2026-04-06
The primary treatment for Stevens Johnson Syndrome (SJS) is the immediate withdrawal of the suspected causative medication followed by specialized supportive care, typically managed in an intensive care unit or burn center. First-Line and Medical Management Because Stevens Johnson Syndrome is a medical emergency, the cornerstone of care is rapid identification and cessation of the drug trigger. Supportive care focuses on fluid resuscitation, electrolyte balance, and meticulous wound care to prevent secondary infections.
5 people with Stevens Johnson Syndrome have shared their first-person experience on this question at DiseaseMaps.
The primary treatment for Stevens Johnson Syndrome (SJS) is the immediate withdrawal of the suspected causative medication followed by specialized supportive care, typically managed in an intensive care unit or burn center.
Because Stevens Johnson Syndrome is a medical emergency, the cornerstone of care is rapid identification and cessation of the drug trigger. Supportive care focuses on fluid resuscitation, electrolyte balance, and meticulous wound care to prevent secondary infections. While there is no universal consensus on systemic therapies, clinicians may consider the use of intravenous immunoglobulin (IVIG) or systemic corticosteroids (such as prednisone or methylprednisolone) to modulate the immune response, though their efficacy remains a subject of ongoing clinical debate.
Managing Stevens Johnson Syndrome requires a coordinated team of specialists. This typically includes dermatologists for skin management, ophthalmologists to monitor and treat potential ocular complications, and burn surgeons for specialized wound care. Depending on the extent of mucosal involvement, pulmonologists, urologists, and gastroenterologists may also be vital members of the care team.
Non-pharmacological intervention is critical in Stevens Johnson Syndrome. This includes the use of non-adherent dressings, specialized nutritional support to promote healing, and physical or occupational therapy to prevent contractures and regain mobility during recovery. Emerging research is investigating the role of cyclosporine and biological agents like etanercept (Enbrel) in clinical trials, though these are not yet considered standard of care. Treatment effectiveness varies significantly between patients based on the extent of skin detachment, the speed of diagnosis, and the individual's underlying health status.
Medical Disclaimer: This information is for educational purposes only and does not constitute medical advice. Treatment for Stevens Johnson Syndrome must be highly personalized and managed by a specialized medical team based on your specific clinical presentation. Always consult your healthcare providers regarding your unique treatment plan.